System Formulary Update
Antineoplastic Agents
Situation
The evaluation to update restrictions on Antineoplastic agents for outpatient use only was approved in July 2022.
Background
A review was conducted on the current System and Medical Center restriction criteria on antineoplastic agents and identified a list of potential medications that could be restricted for “outpatient use only” at the System and Medical Center level.
Assessment/Recommendations
System P&T voted to restrict the following products to outpatient, clinic use only (i.e. no inpatient use) at UNC Medical Center and a System-level:
Formulary/Epic changes will Go-Live on Tuesday, August 30, 2022.